Showing results (121-130 of 217) with videos related to
Sort By:
Pageof 22
Gynecologic Oncology|July 27, 2015
Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancerHaider Mahdi, Allison Gockley, Katherine Esselen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of ChemoradiotherapyPeter G Rose, James Java, Charles W Whitney, et al.Gynecologic Oncology|August 6, 2014
A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: an NRG Oncology/Gynecologic Oncology Group StudyLinda R Duska, John A Blessing, Jacob Rotmensch, et al.Journal of Gynecology Obstetrics and Human Reproduction|June 27, 2020
Effect of platinum sensitivity on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent epithelial ovarian cancerAnthony B Costales, Laura Chambers, Anna Chichura, et al.Gynecologic Oncology|May 1, 2024
Extended-duration antibiotics are not associated with a reduction in surgical site infection in patients with ovarian cancer undergoing cytoreductive surgery with large bowel resectionJulia Chalif, Laura M Chambers, Meng Yao, et al.Gynecologic Oncology|March 11, 2022
Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancerJulia Chalif, Meng Yao, Morgan Gruner, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 11, 2026
Interval versus primary cytoreductive surgery in BRCA-mutated advanced-stage ovarian/peritoneal/tubal carcinomaPeter G Rose, Sujata Patil, Meng Yao, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 6, 2023
Efficacy and toxicity of carboplatin and gemcitabine administered on day 1 and day 8 (day1&8) versus day 1-only for platinum-sensitive recurrent epithelial ovarian cancerErika J Lampert, Peter G Rose, Meng Yao, et al.Gynecologic Oncology|April 25, 2013
Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical centerJessica Moline, Haider Mahdi, Bin Yang, et al.Gynecologic Oncology Reports|November 11, 2021
Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinomaLaura M Chambers, Danielle Chau, Meng Yao, et al.Pageof 22